Page last updated: 2024-08-23

captopril and Congenital Adrenal Hyperplasia

captopril has been researched along with Congenital Adrenal Hyperplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iacobone, M; Lenzini, L; Lerco, S; Maiolino, G; Prisco, S; Rossi, GP; Seccia, TM; Torresan, F; Vanderriele, PE	1

Other Studies

1 other study(ies) available for captopril and Congenital Adrenal Hyperplasia

Article	Year
PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy. The Journal of clinical endocrinology and metabolism, 2019, 09-01, Volume: 104, Issue:9 Topics: Adenoma; Adrenal Hyperplasia, Congenital; Adrenalectomy; Aldosterone; Angiotensin II; Antihypertensive Agents; Biomarkers; Captopril; Cells, Cultured; Disorder of Sex Development, 46,XY; Essential Hypertension; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Male; Middle Aged; Parathyroid Hormone; Prognosis; Prospective Studies; Vasoconstrictor Agents	2019

Article

Year

PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.

The Journal of clinical endocrinology and metabolism, 2019, 09-01, Volume: 104, Issue:9

Topics: Adenoma; Adrenal Hyperplasia, Congenital; Adrenalectomy; Aldosterone; Angiotensin II; Antihypertensive Agents; Biomarkers; Captopril; Cells, Cultured; Disorder of Sex Development, 46,XY; Essential Hypertension; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Male; Middle Aged; Parathyroid Hormone; Prognosis; Prospective Studies; Vasoconstrictor Agents

2019